Copy Number Variation Analysis in Turkish Patients with Congenital Bilateral Absence of Vas Deferens

Total Page:16

File Type:pdf, Size:1020Kb

Copy Number Variation Analysis in Turkish Patients with Congenital Bilateral Absence of Vas Deferens RESEARCH ARTICLE Acta Medica Alanya 2021;5(2): 181-189 ARAŞTIRMA DOI:10.30565/medalanya.966940 Copy Number Variation Analysis in Turkish Patients with Congenital Bilateral Absence of Vas Deferens Konjenital Bilateral Vas Deferens Yokluğu Olan Türk Hastalarda Genomik Kopya Sayısı Varyasyonları Analizi Durkadin Demir Eksi1*, Elanur Yilmaz², Yigit Akin3, Mustafa Faruk Usta4, Mehmet Murad Basar5, Semra Kahraman⁶, Munire Erman⁷, Ozgul M Alper⁸ 1. Alanya Alaaddin Keykubat University, Faculty of Medicine, Department of Medical Biology, Antalya, Turkey 2. Koç University, Research Center of Translational Medicine İstanbul, Turkey 3. İzmir Katip Çelebi University, Faculty of Medicine, Department of Urology, İzmir, Turkey 4. Akdeniz University, Faculty of Medicine, Department of Urology, Antalya, Turkey 5. Memorial Şişli Hospital, Department of Urology, İstanbul, Turkey 6. Memorial Şişli Hospital, Department of Gynecology and Obstetrics, İstanbul, Turkey 7. Akdeniz University, Faculty of Medicine, Department of Gynecology and Obstetrics, Antalya, Turkey 8. Akdeniz University, Faculty of Medicine, Department of Medical Biology and Genetics, Antalya, Turkey ABSTRACT ÖZ Objective: Congenital Bilateral Absence of the Vas Deferens (CBAVD) is a Amaç: Konjenital Bilateral Vas Deferens Yokluğu (CBAVD), erkeklerde infertiliteye developmental abnormality that causes infertility in males. According to the yol açan gelişimsel bir anomalidir. Literatüre göre CBAVD’li olguların %88’e kadarı en literature, up to 88% of CBAVD cases have at least one pathogenic Cystic Fibrosis az bir Kistik Fibrozis Transmembran Regülatör geni (CFTR) mutasyonuna sahiptir. Transmembrane Conductance Regulator gene (CFTR) mutation. However, based on Ancak, daha önceki verilerimize göre CBAVD’li Türk hastalarda bu oran %15.90’dır. our previous data, this rate was 15.90% in Turkish patients with CBAVD. We aimed Çalışmamız kapsamında Türk popülasyonundaki CBAVD ile ilişkili olabilecek to identify genomic copy number variations (CNV) and candidate genomic regions genomik kopya sayısı varyasyonları (CNV) ve aday genomik bölgelerin tanımlanması which could related to the CBAVD in Turkish population. amaçlanmıştır. Methods: CNV analysis was performed in 19 Turkish CBAVD patients normal Yöntemler: Normal karyotipe ve yabanıl tip CFTR genotipine sahip 19 Türk CBAVD’li karyotypes and a wild type CFTR genotype. We suggested that the DAD1 gene may hastanın CNV analizi gerçekleştirildi. CNV bulgularımızın analizi ve veritabanlarının be a candidate gene related to CBAVD by reviewing online databases and analyzing taranması ile DAD1 geni CBAVD ile ilişkili olabilecek potansiyel aday gen olarak CNV findings. Sanger sequencing of the DAD1 gene exons was performed in 22 tanımlandı. 22 CBAVD’li hastada da DAD1 geni ekzonlarının dizi analizi Sanger patients. dizileme metoduyla yapıldı. Results: We identified 11 CNVs that most likely related with the disease in nine of Bulgular: 19 hastanın dokuzunda (%47.3) hastalıkla ilişkili olabilecek 11 adet 19 (47.3%) patients. As the most common CNV, 14q11.2 deletions were detected in CNV saptandı. En sık saptanan CNV olarak 14q11.2 delesyonu, hastaların üçünde there (15.79%) of the patients. There was only DAD1 gene in the sharing genomic (%15.79) belirlendi. 14q11.2 delesyonlarından ikisinin ortak varyant bölgesinde region of two of the 14q11.2 deletions. No sequence variation was detected in the yalnızca DAD1 geni lokalize idi. Dizi analizi ile, hastaların DAD1 geninde herhangi DAD1 gene of the patients. bir dizi varyasyonu saptanmadı. Conclusion: The 14q11.2 chromosomal region and the DAD1 gene may be Sonuç: 14q11.2 kromozomal bölgesi ve DAD1 geni CBAVD ile ilişkili olabilir. associated with CBAVD. Further studies are needed to indentify the contribution of CNVlerin ve DAD1 geninin CBAVD etiyolojisine katkısını tanımlamak için ileri CNVs and DAD1 gene to CBAVD etiology. çalışmalar gerekmektedir. Keywords: copy number variations; CBAVD; male infertility; DAD1 Anahtar Kelimeler: kopya sayısı varyasyonları; CBAVD; erkek infertilitesi, DAD1 Received: 10.07.2021 Accepted: : 01.08.2021 Published (Online): 30.08.2021 *Coresponding Author: Durkadin Demir Eksi, Asst. Professor, Ph.D. Alanya Alaaddin Keykubat University, Faculty of Medicine, Department of Medical Biology, Kestel Campus Alanya, Antalya, Turkey 07425. Phone: +90 242 510 6060 / 3570 Fax: +90 242 510 6009 E-mail: [email protected]. ORCID: 0000-0002-5887-3141. To cited: Demir Eksi D, Yilmaz E, Akin Y, Usta MF, Basar MM, Kahraman S, Erman M, Alper OM. Copy Number Variation Analysis in Turkish Patients with Congenital Bilateral Absence of Vas Deferens. Acta Med. Alanya 2021;5(2): 181-189 doi:10.30565/medalanya.966940 Acta Medica Alanya MAY- AUG 2021 Open Access http://dergipark.gov.tr/medalanya. 181 This article is distributed under the terms of the Creative Commons Attribution 4.0 International License. Demir Eksi D. et al. CNV Analysis in Patients with CBAVD INTRODUCTION gene fusion, position effect and other effects on gene function [13]. To date, CNV analyses s a global health problem, infertility affects for idiopathic azoospermia from different ethnic approximately 8-12% of all couples [1]. It has A backgrounds or populations have been performed been estimated that 40-50% of all infertility cases is in several studies [14, 15]. We hypothesise that due to ‘male factor’ infertility and affects about 7% CNVs might explain, at least partially, the unknown of all men [1]. Congenital structural anomalies of the genetic etiology of CBAVD. Therefore, we aimed male genital tract are contributing factors in male to identify the possible candidate genomic infertility. Numerical or structural chromosomal regions and genes which could cause CBAVD in abnormalities, Y chromosome microdeletions, Turkish patients not carrying CFTR mutations by and Cystic Fibrosis Transmembrane Conductance performing whole genome CNV analysis. Here, we Regulator (CFTR, NM_000492.3) gene mutations report that Defender Against Cell Death 1 (DAD1) associated with congenital bilateral absence of localized at 14q11.2 in our cohort is a gene that vas deferens (CBAVD, OMIM 277180) are the may need to be investigated further in association most common genetic reasons of male infertility with CBAVD. DAD1 is known to be a negative [2]. CBAVD accounts for 1-2% of all male infertility, regulator of apoptosis [16]. which is a condition characterized by the blockade of the transportation of the spermatozoa from MATERIALS AND METHODS testicular or epididymal structures to the distal genital tract, resulting in azoospermia [3]. 88% Ethical approval and patients of Caucasian, 78% of Non-Caucasian patients This clinico-genetic study was conducted with with CBAVD carry at least one CFTR mutation the collaboration of Akdeniz University Faculty of [4]. However, CFTR mutations were found to be Medicine, Izmir Katip Celebi University Faculty of less common in Turkish CBAVD patients [5-7]. We Medicine, and Istanbul Sisli Memorial Hospital, previously reported that only 15.90% had CFTR Turkey. The study protocol was approved by mutations [7]. The lower frequency of CFTR the Akdeniz University Clinical Research Ethics mutations among Turkish CBAVD cases, as well Committee (approval No: 2014-# 383) under as differential mutation profiles, demonstrated the the recent version of the Helsinki Declaration. impact of geographical and ethnic backgrounds on Informed consent was obtained from all subjects CBAVD etiology [5, 7]. Besides CFTR, ADGRG2 when they were enrolled in the study. (Adhesion G protein-Coupled Receptor G2) gene variants were identified as a cause of CBAVD The patients who applied to the urology outpatient with a prevalence of 7.4% and 20% in French and clinic due to primary infertility were evaluated. Chinese cases, respectively [8, 9]. Recently, it was All of the patients had not used any birth control shown that, heterozygous SLC9A3 deletions were method for at least one year, they had no sexual found in 37.9% of the Taiwanese patients, and dysfunction and no comorbidity. Twenty-two SCNN1B and CA12 genes regulating CFTR protein unrelated, adult Anatolia-originated Caucasian levels were found to be associated with CBAVD males with CBAVD were included in the study. All in some patients without CFTR mutations [10, 11]. patients were azoospermic. CBAVD patients were Nevertheless, these gene variations explain the determined by using physical examination, scrotal, disease in only a limited fraction of all CBAVD transrectal ultrasound (USG), semen analysis, patients. The genetic structure of the present day and biochemical tests. CBAVD cases with wild- Turkish people may not be similar with Europeans type CFTR genotype, normal karyotype, without a or Asians because of migrations from different Y chromosome microdeletion were included in this geographical areas [12]. We hypothesized novel study. Renal aplasia was excluded by pelvic USG. genes and/or genomic regions may be related to idiopathic CBAVD in Turkish people. Copy Number Variation Analysis Genomic copy number variations (CNVs) can For molecular genetic analyses, patients’ genomic lead to disease by various molecular mechanisms DNA was isolated from peripheral blood by using including gene dosage effect, gene disruption, a non-enzymatic method modified from Lahiri and Acta Medica Alanya 2021:5:2 182 Demir Eksi D. et al. CNV Analysis in Patients with CBAVD Nurnberger [17]. The quality of DNA samples was for CBAVD. The gene with a possible role in the tested by agarose gel
Recommended publications
  • Methods for Using Small Non-Coding Rnas to Improve Recombinant Protein Expression in Mammalian Cells
    G C A T T A C G G C A T genes Review Methods for Using Small Non-Coding RNAs to Improve Recombinant Protein Expression in Mammalian Cells Sarah Inwood 1,2 ID , Michael J. Betenbaugh 2 and Joseph Shiloach 1,* 1 Biotechnology Core Laboratory, NIDDK, NIH, Bethesda, MD 20892, USA; [email protected] 2 Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD 21218, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-301-496-9719 Received: 17 November 2017; Accepted: 3 January 2018; Published: 9 January 2018 Abstract: The ability to produce recombinant proteins by utilizing different “cell factories” revolutionized the biotherapeutic and pharmaceutical industry. Chinese hamster ovary (CHO) cells are the dominant industrial producer, especially for antibodies. Human embryonic kidney cells (HEK), while not being as widely used as CHO cells, are used where CHO cells are unable to meet the needs for expression, such as growth factors. Therefore, improving recombinant protein expression from mammalian cells is a priority, and continuing effort is being devoted to this topic. Non-coding RNAs are RNA segments that are not translated into a protein and often have a regulatory role. Since their discovery, major progress has been made towards understanding their functions. Non-coding RNA has been investigated extensively in relation to disease, especially cancer, and recently they have also been used as a method for engineering cells to improve their protein expression capability. In this review, we provide information about methods used to identify non-coding RNAs with the potential of improving recombinant protein expression in mammalian cell lines.
    [Show full text]
  • A 40-Cm Region on Chromosome 14 Plays a Critical Role in the Development of Virus Persistence, Demyelination, Brain Pathology An
    A 40-cM Region on Chromosome 14 Plays a Critical Role in the Development of Virus Persistence, Demyelination, Brain Pathology and Neurologic Deficits in a Murine Viral Model of Multiple Sclerosis Shunya Nakane, Laurie Zoecklein, Jeffrey Gamez, Louisa Papke, Kevin Pavelko, Jean- François Bureau, Michel Brahic, Larry Pease, Moses Rodriguez To cite this version: Shunya Nakane, Laurie Zoecklein, Jeffrey Gamez, Louisa Papke, Kevin Pavelko, et al.. A 40-cM Region on Chromosome 14 Plays a Critical Role in the Development of Virus Persistence, Demyelination, Brain Pathology and Neurologic Deficits in a Murine Viral Model of Multiple Sclerosis. Brain Pathology, Wiley, 2003, 13 (4), pp.519-533. 10.1111/j.1750-3639.2003.tb00482.x. hal-03223233 HAL Id: hal-03223233 https://hal.archives-ouvertes.fr/hal-03223233 Submitted on 10 May 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. RESEARCH ARTICLE A 40-cM Region on Chromosome 14 Plays a Critical Role in the Development of Virus Persistence, Demyelination, Brain Pathology and Neurologic Deficits in a Murine Viral Model of Multiple Sclerosis Shunya Nakane1; Laurie J. Zoecklein1; Jeffrey D. Introduction Gamez1; Louisa M. Papke1; Kevin D.
    [Show full text]
  • The Highly Conserved Defender Against the Death 1 (DAD1) Gene
    FEBS Letters 363 (1995) 304-306 FEBS 15393 The highly conserved defender against the death 1 (DAD 1) gene maps to human chromosome 14qll-q12 and mouse chromosome 14 and has plant and nematode homologs Suneel S. Apte"'*, Marie-Genevieve Mattei b, Michael F. Seldin c, Bjorn R. Olsen a aDepartment of Cell Biology, Harvard Medical School, 25 Shattuck St., Boston, MA 02115, USA bHopital d'Enfants, INSERM U 406, Groupe Hospitalier de la Timone, 13385 Marseille Cedex 5, France CDepartments of Medicine and Microbiology, Duke University School of Medicine, Box 3380, Durham, NC 27710, USA Received 8 March 1995 demonstrated the remarkable degree of conservation of this Abstract We have cloned the cDNA encoding the mouse DAD1 protein in these 3 species [5]. It is identical in humans and (defender against apoptotic cell death) protein. While showing an hamster and varies only slightly in Xenopus. No homologies expected high homology with the previously cloned human and with previously isolated genes have been reported, and neither Xenopus DADl-encoding cDNAs, this sequence has striking ho- mology to partial eDNA sequences reported from Oo sativa (rice) the precise intracellular localization nor the protein-protein and C. elegans (nematode), suggesting the existence of plant and interactions of DAD1 are currently known [5]. invertebrate homologs of this highly conserved gene. The human We report the cloning of the mouse Dadl eDNA. As ex- and mouse DAD1 genes map to chromosome 14qll-q12 and pected, this is similar to the previously cloned human and chromosome 14, respectively. This mapping data supports and hamster cDNAs.
    [Show full text]
  • Novel Targets of Apparently Idiopathic Male Infertility
    International Journal of Molecular Sciences Review Molecular Biology of Spermatogenesis: Novel Targets of Apparently Idiopathic Male Infertility Rossella Cannarella * , Rosita A. Condorelli , Laura M. Mongioì, Sandro La Vignera * and Aldo E. Calogero Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy; [email protected] (R.A.C.); [email protected] (L.M.M.); [email protected] (A.E.C.) * Correspondence: [email protected] (R.C.); [email protected] (S.L.V.) Received: 8 February 2020; Accepted: 2 March 2020; Published: 3 March 2020 Abstract: Male infertility affects half of infertile couples and, currently, a relevant percentage of cases of male infertility is considered as idiopathic. Although the male contribution to human fertilization has traditionally been restricted to sperm DNA, current evidence suggest that a relevant number of sperm transcripts and proteins are involved in acrosome reactions, sperm-oocyte fusion and, once released into the oocyte, embryo growth and development. The aim of this review is to provide updated and comprehensive insight into the molecular biology of spermatogenesis, including evidence on spermatogenetic failure and underlining the role of the sperm-carried molecular factors involved in oocyte fertilization and embryo growth. This represents the first step in the identification of new possible diagnostic and, possibly, therapeutic markers in the field of apparently idiopathic male infertility. Keywords: spermatogenetic failure; embryo growth; male infertility; spermatogenesis; recurrent pregnancy loss; sperm proteome; DNA fragmentation; sperm transcriptome 1. Introduction Infertility is a widespread condition in industrialized countries, affecting up to 15% of couples of childbearing age [1]. It is defined as the inability to achieve conception after 1–2 years of unprotected sexual intercourse [2].
    [Show full text]
  • 14Q11.2 Deletions FTNW
    14q11.2 deletions rarechromo.org 14q11.2 deletions A chromosome 14 deletion means that part of one of the body’s chromosomes (chromosome 14) has been lost or deleted. If the material that has been deleted contains important genes, learning disability, developmental delay and health problems may occur. How serious these problems are depends on how much of the chromosome has been deleted and where precisely the deletion is. Genes and chromosomes Our bodies are made up of billions of cells. Most of these cells contain a complete set of thousands of genes that act as instructions, controlling growth, development and how our bodies work. Inside human cells there is a nucleus where the genes are carried on microscopically small, thread-like structures called chromosomes which are made up of DNA. Chromosomes come in pairs of different sizes and are numbered 1-22 from largest to smallest, roughly according to their size. In addition to these so-called autosomal chromosomes there are the sex chromosomes, X and Y. So a human cell has 46 p arm p arm chromosomes: 23 inherited from the mother and 23 p arm p arm inherited from the father, making two sets of 23 chromosomes. A girl will have two X chromosomes (XX) while a boy will have one X and one Y chromosome (XY). Each chromosome has a short (p) arm (at the top in the diagram on this page) and a long (q) arm (at the bottom of the diagram). In a 14q deletion, material has been lost from the long arm of one chromosome 14.
    [Show full text]
  • 14Q11.2 Deletions FTNP
    Support and Information Rare Chromosome Disorder Support Group, G1, The Stables, Station Road West, Oxted, Surrey RH8 9EE, United Kingdom Tel/Fax: +44(0)1883 723356 [email protected] III www.rarechromo.org Unique is a charity without government funding, existing entirely on donations 14q11.2 deletions and grants. If you are able to support our work in any way, however small, please make a donation via our website at www.rarechromo.org/html/MakingADonation.asp Please help us to help you! This information guide is not a substitute for personal medical advice. Families should consult a medically qualified clinician in all matters relating to genetic diagnosis, management and health. Information on genetic changes is a very fast-moving field and while the information in this guide is believed to be the best available at the time of publication, some facts may later change. Unique does its best to keep abreast of changing information and to review its published guides as needed. It was compiled by Unique and reviewed by Jana Drábová, Division of Medical Cytogenetics, Department of Biology and Medical Genetics, Charles University 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic. 2016 Version 1 (PM) Copyright © Unique 2016 20 Rare Chromosome Disorder Support Group Charity Number 1110661 Registered in England and Wales Company Number 5460413 rarechromo.org 14q11.2 deletions Genes A chromosome 14 deletion means that part of one of the body’s chromosomes (chromosome 14) has been lost or deleted. If the material that has been deleted contains important genes, learning disability, developmental delay and health HNRNPC problems may occur.
    [Show full text]
  • Table S1. 103 Ferroptosis-Related Genes Retrieved from the Genecards
    Table S1. 103 ferroptosis-related genes retrieved from the GeneCards. Gene Symbol Description Category GPX4 Glutathione Peroxidase 4 Protein Coding AIFM2 Apoptosis Inducing Factor Mitochondria Associated 2 Protein Coding TP53 Tumor Protein P53 Protein Coding ACSL4 Acyl-CoA Synthetase Long Chain Family Member 4 Protein Coding SLC7A11 Solute Carrier Family 7 Member 11 Protein Coding VDAC2 Voltage Dependent Anion Channel 2 Protein Coding VDAC3 Voltage Dependent Anion Channel 3 Protein Coding ATG5 Autophagy Related 5 Protein Coding ATG7 Autophagy Related 7 Protein Coding NCOA4 Nuclear Receptor Coactivator 4 Protein Coding HMOX1 Heme Oxygenase 1 Protein Coding SLC3A2 Solute Carrier Family 3 Member 2 Protein Coding ALOX15 Arachidonate 15-Lipoxygenase Protein Coding BECN1 Beclin 1 Protein Coding PRKAA1 Protein Kinase AMP-Activated Catalytic Subunit Alpha 1 Protein Coding SAT1 Spermidine/Spermine N1-Acetyltransferase 1 Protein Coding NF2 Neurofibromin 2 Protein Coding YAP1 Yes1 Associated Transcriptional Regulator Protein Coding FTH1 Ferritin Heavy Chain 1 Protein Coding TF Transferrin Protein Coding TFRC Transferrin Receptor Protein Coding FTL Ferritin Light Chain Protein Coding CYBB Cytochrome B-245 Beta Chain Protein Coding GSS Glutathione Synthetase Protein Coding CP Ceruloplasmin Protein Coding PRNP Prion Protein Protein Coding SLC11A2 Solute Carrier Family 11 Member 2 Protein Coding SLC40A1 Solute Carrier Family 40 Member 1 Protein Coding STEAP3 STEAP3 Metalloreductase Protein Coding ACSL1 Acyl-CoA Synthetase Long Chain Family Member 1 Protein
    [Show full text]
  • Gene Expression Profiling Induced by Histone Deacetylase Inhibitor, FK228, in Human Esophageal Squamous Cancer Cells
    585-592 25/7/07 16:27 Page 585 ONCOLOGY REPORTS 18: 585-592, 2007 585 Gene expression profiling induced by histone deacetylase inhibitor, FK228, in human esophageal squamous cancer cells ISAMU HOSHINO, HISAHIRO MATSUBARA, YASUNORI AKUTSU, TAKANORI NISHIMORI, YASUO YONEYAMA, KENTARO MURAKAMI, AKI KOMATSU, HARUHITO SAKATA, KAZUYUKI MATSUSHITA and TAKENORI OCHIAI Department of Frontier Surgery, Chiba University, Graduate School of Medicine, Chiba, Japan Received March 31, 2007; Accepted May 29, 2007 Abstract. Histone deacetylase inhibitors (HDACIs) are optimal chemotherapy agents for ESCC (3). However, the promising therapeutic agents with the potential for regulating response rates of these combination chemotherapies are not cell cycle, differentiation and apoptosis in cancer cells. satisfactory and the development of new anticancer drugs is HDACI activity is associated with selective transcriptional expected to improve the prognosis of ESCC. Histone regulation and altering gene expression. However, the exact deacetylase inhibitors (HDACIs) are considered to represent mechanisms leading to the antitumor effect of HDACIs are one of the most promising agents for this purpose. not fully understood. FK228, one of the powerful HDACIs, The balance of acetylation by histone acetylases and strongly inhibited cell growth of T.Tn and TE2 cells and deacetylation by histone deacetylase prevents full acetylation, induced apoptosis. Therefore, comprehensive analysis of the thereby creating a default underacetylated state. Acetylated changes in gene expression in human esophageal cancer cell histone tails and other chromosome-associated proteins have lines by the HDACI FK228 was carried out by microarray been identified in nucleosomes and shown to be important in analysis. This analysis was used to clarify the expression regulating gene expression (4,5).
    [Show full text]
  • OXI1 and DAD Regulate Light-Induced Cell Death Antagonistically Through Jasmonate and Salicylate Levels1
    OXI1 and DAD Regulate Light-Induced Cell Death Antagonistically through Jasmonate and Salicylate Levels1 Inès Beaugelin,a Anne Chevalier,a Stefano D’Alessandro,a Brigitte Ksas,a Ondrej Novák,b Miroslav Strnad,b Céline Forzani,c Heribert Hirt,d Michel Havaux,a,2,3 andFabienMonneta,e aAix-Marseille University, Centre National de la Recherche Scientifique, Commissariat à l’Energie Atomique et aux Energies Alternatives, UMR 7265 Biosciences and Biotechnologies Institute of Aix- Marseille, CEA/ Cadarache, F-13108 Saint-Paul-lès-Durance, France bLaboratory of Growth Regulators, Institute of Experimental Botany, The Czech Academy of Sciences, Palacký University, CZ‐78371 Olomouc, Czech Republic cInstitut Jean-Pierre Bourgin, Institut National de la Recherche Agronomique, AgroParisTech, Centre National de la Recherche Scientifique, Université Paris-Saclay, F-78000 Versailles, France dCenter for Desert Agriculture, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia eUniversité d’Avignon et des Pays de Vaucluse, F-84000 Avignon, France ORCID IDs: 0000-0001-7618-9047 (I.B.); 0000-0002-0464-5549 (S.D.); 0000-0002-5369-3176 (B.K.); 0000-0002-2806-794X (M.S.); 0000-0003-3119-9633 (H.H.); 0000-0002-6434-393X (M.H.). Singlet oxygen produced from triplet excited chlorophylls in photosynthesis is a signal molecule that can induce programmed cell death (PCD) through the action of the OXIDATIVE STRESS INDUCIBLE 1 (OXI1) kinase. Here, we identify two negative regulators of light-induced PCD that modulate OXI1 expression: DAD1 and DAD2, homologs of the human antiapoptotic protein DEFENDER AGAINST CELL DEATH. Overexpressing OXI1 in Arabidopsis (Arabidopsis thaliana) increased plant sensitivity to high light and induced early senescence of mature leaves.
    [Show full text]
  • Evidence for RPGRIP1 Gene As Risk Factor for Primary Open Angle Glaucoma
    European Journal of Human Genetics (2011) 19, 445–451 & 2011 Macmillan Publishers Limited All rights reserved 1018-4813/11 www.nature.com/ejhg ARTICLE Evidence for RPGRIP1 gene as risk factor for primary open angle glaucoma Lorena Ferna´ndez-Martı´nez1, Stef Letteboer2, Christian Y Mardin3, Nicole Weisschuh4, Eugen Gramer5, Bernhard HF Weber6, Bernd Rautenstrauss1,8, Paulo A Ferreira7, Friedrich E Kruse3, Andre´ Reis1, Ronald Roepman2 and Francesca Pasutto*,1 Glaucoma is a genetically heterogeneous disorder and is the second cause of blindness worldwide owing to the progressive degeneration of retinal ganglion neurons. Very few genes causing glaucoma were identified to this date. In this study, we screened 10 candidate genes of glaucoma between the D14S261 and D14S121 markers of chromosome 14q11, a critical region previously linked to primary open-angle glaucoma (POAG). Mutation analyses of two large cohorts of patients with POAG, normal tension glaucoma (NTG) and juvenile open-angle glaucoma (JOAG), and control subjects, found only association of non-synonymous heterozygous variants of the retinitis pigmentosa GTPase regulator-interacting protein 1 (RPGRIP1) with POAG, NTG and JOAG. The 20 non-synonymous variants identified in RPGRIP1 were all distinct from variants causing photoreceptor dystrophies and were found throughout all but one domain (RPGR-interacting domain) of RPGRIP1. Among them, 14 missense variants clustered within or around the C2 domains of RPGRIP1. Yeast two-hybrid analyses of a subset of the missense mutations within the C2 domains of RPGRIP1 shows that five of them (p.R598Q, p.A635G, p.T806I, p.A837G and p.I838V) decrease the association of the C2 domains with nephrocystin-4 (NPHPH).
    [Show full text]
  • High-Resolution Genomic Profiling Reveals Gain of Chromosome 14 As
    Endocrine-Related Cancer (2009) 16 953–966 High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids Ellinor Andersson1, Christina Swa¨rd 2,Go¨ran Stenman1,Ha˚kan Ahlman 2 and Ola Nilsson1 1Lundberg Laboratory for Cancer Research, Department of Pathology and 2Lundberg Laboratory for Cancer Research, Department of Surgery, Sahlgrenska University Hospital, Gula Stra˚ket 8, SE-413 45 Go¨teborg, Sweden (Correspondence should be addressed to O Nilsson; Email: [email protected]) Abstract Ileal carcinoids are malignant neuroendocrine tumours of the small intestine. The aim of this study was to obtain a high-resolution genomic profile of ileal carcinoids in order to define genetic changes important for tumour initiation, progression and survival. Forty-three patients with ileal carcinoids were investigated by high-resolution array-based comparative genomic hybridization. The average number of copy number alterations (CNAs) per tumour was 7.1 (range 1–22), with losses being more common than gains (ratio 1.4). The most frequent CNA was loss of chromosome 18 (74%). Other frequent CNAs were gain of chromosome 4, 5, 14 and 20, and loss of 11q22.1–q22.2, 11q22.3–q23.1 and 11q23.3, and loss of 16q12.2–q22.1 and 16q23.2-qter. Two distinct patterns of CNAs were found; the majority of tumours was characterized by loss of chromosome 18 while a subgroup of tumours had intact chromosome 18, but gain of chromosome 14. Survival analysis, using a series of Poisson regressions including recurrent CNAs, demonstrated that gain of chromosome 14 was a strong predictor of poor survival.
    [Show full text]